U-Blot® Research Grade Anti-Human CD70 (SGN-CD70A)Cat. No. WA1768Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD70 (SGN-CD70A)Cat. No. WA1768
U-Blot® Research Grade Anti-Human CD70 (MDX-1411)Cat. No. WA1767
U-Blot® Research Grade Anti-Human CD70 (BMS936561)Cat. No. WA1766
U-Blot® Research Grade Anti-Human CD70 (AMG 172)Cat. No. WA1765
U-Blot® Research Grade Anti-Human CD7 (GC027)Cat. No. WA1764
U-Blot® Research Grade Anti-Human CD66e/CEA/CEACAM5 (SGM 101)Cat. No. WA1763
U-Blot® Research Grade Anti-Human CD66e/CEA/CEACAM5 (Kab201)Cat. No. WA1762
U-Blot® Research Grade Anti-Human CD66e/CEA/CEACAM5 (BDC-2034)Cat. No. WA1761
U-Blot® Research Grade Anti-Human CD66e/CEA/CEACAM5 (A5B7)Cat. No. WA1760
U-Blot® Research Grade Anti-Human CD66e/CEA/CEACAM5 (16C3)Cat. No. WA1759
U-Blot® Research Grade Anti-Human CD66c/CEACAM6 (NOV1803)Cat. No. WA1758
U-Blot® Research Grade Anti-Human CD66c/CEACAM6 (NEO-201)Cat. No. WA1757